Moderna Inc

NASDAQ:MRNA  
430.06
-10.59 (-2.40%)
5:12:40 PM EDT: $428.83 -1.23 (-0.29%)
Products

Moderna Highlights New Clinical Data On Its Covid-19 Vaccine

Published: 09/15/2021 20:06 GMT
Moderna Inc (MRNA) - Moderna Highlights New Clinical Data on Its Covid-19 Vaccine.
Moderna Inc - Mrna-1273 Remains Highly Effective Against Covid-19 in Real-world Effectiveness Study During Surge in Delta Cases.
Moderna Inc - Mrna-1273 Remains Highly Effective Against Covid-19 in Real-world Effectiveness Study During Surge in Delta Cases.
Moderna Inc - Company Believes Data Support Benefit of an Mrna-1273 Booster Dose.
Moderna - Analysis of Open-label Portion of Phase 3 Cove Study Shows Lower Risk of Breakthrough Infection in Participants Vaccinated More Recently.